CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell TrialNirali N. Shah, Terry J. Fry, Amanda K. Ombrello et al.|Journal of Clinical Oncology|2020Cited by 422
Abstract CT051: Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refractory ALLHaneen Shalabi, Nirali N. Shah, Bonnie Yates et al.|Cancer Research|2020Cited by 8
Abstract LB-146: Phase I CD22 CAR T-cell trial updatesNirali N. Shah, Terry J. Fry, Haneen Shalabi et al.|Cancer Research|2019Cited by 4
Abstract LB-146: Phase I CD22 CAR T-cell trial updatesNirali N. Shah, Terry J. Fry, Haneen Shalabi et al.|Clinical Research (Excluding Clinical Trials)|2019Cited by 1
Herpes Zoster Virus (HZV) Infections among Multiple Sclerosis Patients Treated with Various Disease Modifying Therapies (4954)Nicola Carlisle, Ahmed Z. Obeidat, Sam Hooshmand et al.|Neurology|2020Cited by 0